These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 13582532)

  • 1. [The subcutaneous assay of corticotrophin A. III. A cross-over design using a corticotrophin A standard preparation].
    RERUP C
    Acta Endocrinol (Copenh); 1958 Sep; 29(1):70-82. PubMed ID: 13582532
    [No Abstract]   [Full Text] [Related]  

  • 2. Omega-3 status and cerebrospinal fluid corticotrophin releasing hormone in perpetrators of domestic violence.
    Hibbeln JR; Bissette G; Umhau JC; George DT
    Biol Psychiatry; 2004 Dec; 56(11):895-7. PubMed ID: 15576068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency of the cross-over design: an empirical estimation.
    Garcia R; Benet M; Arnau C; Cobo E
    Stat Med; 2004 Dec; 23(24):3773-80. PubMed ID: 15580599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bioassay of corticotrophin A; with special regard to the effect after subcutaneous administration.
    RERUP C
    Acta Endocrinol Suppl (Copenh); 1958; 29(Supp 42):1-20. PubMed ID: 13605556
    [No Abstract]   [Full Text] [Related]  

  • 5. Validation of the comet-X assay as a pharmacodynamic assay for measuring DNA cross-linking produced by the novel anticancer agent RH1 during a phase I clinical trial.
    Danson S; Ranson M; Denneny O; Cummings J; Ward TH
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):851-61. PubMed ID: 17333193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in vitro assay of corticotrophin.
    McKERNS KW; NORDSTRAND E
    Can J Biochem Physiol; 1955 Mar; 33(2):209-16. PubMed ID: 14352029
    [No Abstract]   [Full Text] [Related]  

  • 7. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
    de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
    Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Third International Standard for Corticotrophin and an International Working Standard for Corticotrophin.
    Can Med Assoc J; 1962 Aug; 87(7):358. PubMed ID: 20327217
    [No Abstract]   [Full Text] [Related]  

  • 9. Conversion from subcutaneous to intravenous erythropoietin in a hemodialysis population.
    Vercaigne LM; Collins DM; Penner SB
    J Clin Pharmacol; 2005 Aug; 45(8):895-900. PubMed ID: 16027399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous administration of nitroglycerin to facilitate radial artery cannulation.
    Pancholy SB; Coppola J; Patel T
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):389-91. PubMed ID: 16892435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some aspects of corticotrophin secretion in the trained dog. I. The presence of a corticotrophin releasing factor in the blood stream of dogs shortly after hypophysectomy.
    EIK-NES KB; BRIZZEE KR
    Acta Endocrinol (Copenh); 1958 Oct; 29(2):219-23. PubMed ID: 13605506
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of preparation designs on the marginal and internal gaps in Cerec3 partial ceramic crowns.
    Seo D; Yi Y; Roh B
    J Dent; 2009 May; 37(5):374-82. PubMed ID: 19282083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioequivalence of liquid and reconstituted lyophilized etanercept subcutaneous injections.
    Sullivan JT; Ni L; Sheelo C; Salfi M; Peloso PM
    J Clin Pharmacol; 2006 Jun; 46(6):654-61. PubMed ID: 16707412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can current physical activity act as a reasonable proxy measure of future physical activity? Evaluating cross-sectional and passive prospective designs with the use of social cognition models.
    Rhodes RE; Plotnikoff RC
    Prev Med; 2005 May; 40(5):547-55. PubMed ID: 15749137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Chinese medicines Chan Su and Lu-Shen-Wan on serum digoxin measurement by Digoxin III, a new digoxin immunoassay.
    Reyes MA; Actor JK; Risin SA; Dasgupta A
    Ther Drug Monit; 2008 Feb; 30(1):95-9. PubMed ID: 18223469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradation of differently cross-linked collagen membranes: an experimental study in the rat.
    Rothamel D; Schwarz F; Sager M; Herten M; Sculean A; Becker J
    Clin Oral Implants Res; 2005 Jun; 16(3):369-78. PubMed ID: 15877758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of spironolactone, potassium canrenoate and their common metabolite canrenone on serum digoxin measurement by digoxin III, a new digoxin immunoassay.
    Dasgupta A; Tso G; Wells A
    Ther Drug Monit; 2008 Dec; 30(6):744-7. PubMed ID: 18824952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of multiplexed, microsphere-based flow cytometric assay for multiple human tumor markers.
    Sun K; Wang Q; Huang XH; Zhen MC; Li W; Zhang LJ
    Acta Pharmacol Sin; 2007 Dec; 28(12):2011-8. PubMed ID: 18031617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
    Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M
    Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.